A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells

International Journal of Biological Sciences

Volumn 5, Issue 6, 2009, Pages 543-548

  Rajik, Mohamed ^a   Omar, Abdul Rahman ^a   Ideris, Aini ^a   Hassan, Sharifah Syed ^b   Yusoff, Khatijah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Flow cytometry; Fluorescence microscopy; Influenza; Peptide inhibitors

Indexed keywords

AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; SPONDIAS PURPUREA;

ANTIVIRUS AGENT; PEPTIDE; PEPTIDE LIBRARY;

ANIMAL; ARTICLE; CELL LINE; DOG; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INFLUENZA VIRUS A H9N2; PHYSIOLOGY; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INFLUENZA A VIRUS, H9N2 SUBTYPE; PEPTIDE LIBRARY; PEPTIDES; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 70350439598     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5.543     Document Type: Article

References (24)

1. Fouchier RA, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol. 2005; 79(5): 2814-2822
2. Hollenbeck JE. An Avian Connection as a Catalyst to the 1918-1919 Influenza Pandemic. Int J Med Sci. 2005; 2(2): 87-90
3. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005; 353(13): 1363-1373
4. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003; 362(9397): 1733-1745
5. Wang C, Takeuchi K, Pinto LH, et al. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol. 1993; 67(9): 5585-5594
6. Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA. 2006; 295(8): 891-894
7. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005; 353(25): 2667-2672
8. Hayden FG. Respiratory viral threats. Curr Opin Infect Dis. 2006; 19(2): 169-178
9. Hurt AC, Selleck P, Komadina N, et al. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res. 2007; 73(3): 228-231
10. Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature. 2005; 437(7062): 1108
11. Puthavathana P, Auewarakul P, Charoenying PC, et al. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol. 2005; 86(2): 423-433
12. Rajik M, Jahanshiri F, Omar AR, et al. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. Virol J. 2009; 6(1): 74
13. Lamb RA, Krug RM. Orthomyxoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds., Fields virology, Philadelphia: Lippincott-Raven Publishers; 1996: 1353-1395.
14. Ramanujam P, Tan WS, Nathan S, et al. Novel peptides that inhibit the propagation of Newcastle disease virus. Arch Virol. 2002; 147(5): 981-993
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-254
16. Hahon N, Booth JA, Eckert HL. Cell attachment and penetration by influenza virus. Infect Immun. 1973; 7(3): 341-351
17. Haywood AM, Boyer BP. Time and temperature dependence of influenza virus membrane fusion at neutral pH. J Gen Virol. 1986; 67 (Pt 12): 2813-2817
18. Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol. 2006; 80(24): 11960-11967
19. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, eds., Fields Virology, Philadelphia: Lippincott-Raven; 1996: 1397-1445.
20. Lakadamyali M, Rust MJ, Zhuang X. Endocytosis of influenza viruses. Microbes Infect. 2004; 6(10): 929-936
21. Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol. 2006; 80(24): 11960-11967
22. Ramalho-Santos J, Nir S, Duzgunes N, et al. A common mechanism for influenza virus fusion activity and inactivation. Biochemistry. 1993; 32(11): 2771-2779
23. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev. 2006; 19(3): 491-511
24. Herz C, Stavnezer E, Krug R, et al. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells. Cell. 1981; 26(3 Pt 1): 391-400